Inhaled iloprost for the treatment of Raynaud's phenomenon

Clinical and Experimental Rheumatology

Volumn 26, Issue 4, 2008, Pages 709-

  Pakozdi, A ^a   Howell, K ^a   Wilson, H ^a   Fox, S ^a   Gonzalez, L ^a   Black, C M ^a   Denton, Christopher P ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FLUSHING; GASTROINTESTINAL SYMPTOM; HUMAN; LETTER; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEBULIZER; OPEN STUDY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RISK FACTOR; SCORING SYSTEM; SIDE EFFECT; SYNCOPE; SYSTEMIC SCLEROSIS; THERMOGRAPHY; VISUAL ANALOG SCALE; VOMITING;

ADMINISTRATION, INHALATION; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; ILOPROST; MALE; MIDDLE AGED; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; VASODILATOR AGENTS;

EID: 52649179435     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (1)

1. OLSCHEWSKI H, SIMONNEAU G, GALIE N et al.: Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002; 347: 322-9.